Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Marius M Hoeper; David B Badesch; H Ardeschir Ghofrani; J Simon R Gibbs; Mardi Gomberg-Maitland; Vallerie V McLaughlin; Ioana R Preston; Rogerio Souza; Aaron B Waxman; Ekkehard Grünig; Grzegorz Kopeć; Gisela Meyer; Karen M Olsson; Stephan Rosenkranz; Yayun Xu; Barry Miller; Marcie Fowler; John Butler; Joerg Koglin; Janethe de Oliveira Pena; Marc Humbert; STELLAR Trial Investigators